With Semaglutide, the active ingredient in Ozempic, Wegovy, and Rybelsus, discontinuing the medication can result in a variety of withdrawal symptoms
Thigh: Inject in an area with fatty tissue on the front of the leg
A representative from Novo Nordisk, the manufacturer of Ozempic and Wegovy, told The New York Post they had received reports of abnormal dreams from users, but since these adverse events are reported voluntarily from a population of uncertain size, it is not possible to reliably estimate their frequency. They added, Novo Nordisk does not have all information pertaining to the patients treatment plan, concomitant medications, and medical conditions
Oguchi S, Walker WA, Sanderson IR
By mimicking the natural hormone GLP-1 (glucagon-like peptide-1), semaglutide significantly reduces appetite, making it easier to achieve and maintain a healthier weight